226883-52-9

Basic information

• Product Name: 5-bromo-2-vinylpyridine
• Synonyms: 5-bromo-2-vinylpyridine
• CAS NO: 226883-52-9
• Molecular Formula: C7H6BrN
• Molecular Weight: 184
• Mol File: 226883-52-9.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 5-bromo-2-vinylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2-vinylpyridine(226883-52-9)
• EPA Substance Registry System: 5-bromo-2-vinylpyridine(226883-52-9)

Safety Data

• Hazardous Substances Data: 226883-52-9(Hazardous Substances Data)

Usage

General Description

5-bromo-2-vinylpyridine is a chemical compound with the molecular formula C7H6BrN. It is a brominated derivative of 2-vinylpyridine and is used in various organic synthesis reactions. 5-bromo-2-vinylpyridine is commonly employed as a building block in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. As a vinylpyridine derivative, it is known for its reactivity in cross-coupling reactions and as a precursor for the modification of polymers and surfaces. Additionally, 5-bromo-2-vinylpyridine is used as a reagent in the synthesis of ligands for metal-catalyzed reactions and as a component in the production of functional materials for various applications.

Upstream product

• 624-28-2 2,5-dibromopyridine 
• 7486-35-3 tri-n-butyl(vinyl)tin 
• 74-85-1 ethene 
• 75927-49-0 pinacol vinylboronate 
• 223463-13-6 2-iodo-5-bromopyridine 

Downstream Products

• 1266569-80-5 C₁₃H₁₁NOS 
• 16222-95-0 2,5-Divinylpyridin 

Relevant articles and documents

INDANYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The present invention relates to compounds of general formula I, wherein the groups R, R1, R2, R3, m and n are as defined herein, which compounds have valuable pharmacological properties, in particular their ability to bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular type 2 diabetes. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.

BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICALCOMPOSITIONS AND USES THEREOF

The present invention relates to compounds of general formula (I), wherein the groups R, R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

ARYLOXYMETHYL CYCLOPROPANE DERIVATIVES AS PDE10 INHIBITORS

The present invention is directed to aryloxymethyl cyclopropane derivatives which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.